Yamanaka-Takaichi, Mika
Ghanian, Soha
Katzka, David A.
Torgerson, Rochelle R.
Alavi, Afsaneh
Article History
Accepted: 15 March 2022
First Online: 15 April 2022
Declarations
:
: No sources of funding were received for the preparation of this article.
: Mika Yamanaka-Takaichi, Soha Ghanian, David A, Katzka, and Rochelle R. Torgerson have no conflicts of interest to disclose. Afsaneh Alavi is a consultant for AbbVie, BI, Janssen, InflaRx, Novartis, and UCB and an investigator for BI, Processa, and Castle Creek.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: MYT and SG performed the literature review and DAK, RRT, and AA edited the manuscript.